KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Edwards Lifesciences (EW) EPS (Weighted Average and Diluted) (2016 - 2025)

Historic EPS (Weighted Average and Diluted) for Edwards Lifesciences (EW) over the last 17 years, with Q3 2025 value amounting to $0.5.

  • Edwards Lifesciences' EPS (Weighted Average and Diluted) fell 9025.34% to $0.5 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.34, marking a year-over-year decrease of 6623.38%. This contributed to the annual value of $4.63 for FY2024, which is 10122.75% up from last year.
  • As of Q3 2025, Edwards Lifesciences' EPS (Weighted Average and Diluted) stood at $0.5, which was down 9025.34% from $0.57 recorded in Q2 2025.
  • In the past 5 years, Edwards Lifesciences' EPS (Weighted Average and Diluted) ranged from a high of $5.13 in Q3 2024 and a low of $0.07 during Q4 2024
  • In the last 5 years, Edwards Lifesciences' EPS (Weighted Average and Diluted) had a median value of $0.58 in 2024 and averaged $0.8.
  • Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first soared by 71428.57% in 2024, then plummeted by 9025.34% in 2025.
  • Edwards Lifesciences' EPS (Weighted Average and Diluted) (Quarter) stood at $0.53 in 2021, then increased by 22.64% to $0.65 in 2022, then fell by 6.15% to $0.61 in 2023, then tumbled by 89.25% to $0.07 in 2024, then surged by 662.47% to $0.5 in 2025.
  • Its EPS (Weighted Average and Diluted) was $0.5 in Q3 2025, compared to $0.57 in Q2 2025 and $0.62 in Q1 2025.